Network origin in Vijay Yabannavar first degree
Entity | Entity type | Industry | |
---|---|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vijay Yabannavar via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Tech/Sci/R&D Officer | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | General Counsel | |
Thomas Jefferson University | College/University | Doctorate Degree | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Corporate Officer/Principal | |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Director/Board Member | |
SYNTHORX, INC. | Biotechnology | Director/Board Member | |
The Warren Alpert Medical School | College/University | Doctorate Degree | |
PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
EDGEWISE THERAPEUTICS, INC. | Biotechnology | Founder | |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Taylor University | College/University | Undergraduate Degree | |
FORTE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | ||
DERMIRA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of San Diego | College/University | Undergraduate Degree | |
Seattle University | College/University | Masters Business Admin | |
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Medical/Nursing Services | Director of Finance/CFO | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
The University of Chicago | College/University | Doctorate Degree | |
The University of Colorado | College/University | Masters Business Admin | |
C.E. Unterberg, Towbin Holdings, Inc.
C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Part of Canaccord Genuity Group, Inc., C.E. Unterberg, Towbin Holdings, Inc. provides financial advisory services. The private company is based in New York, NY. | Investment Managers | Corporate Officer/Principal | |
NORTHWEST BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
APTEVO THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
California University of Pennsylvania | College/University | Undergraduate Degree | |
University of California, Davis | College/University | Undergraduate Degree | |
ATP Capital LP
ATP Capital LP Real Estate DevelopmentFinance ATP Capital LP provides real estate investment and management services. The company was founded by Jonathan R. Malkin in 1997 and is headquartered in Clearwater Beach, FL. | Real Estate Development | Corporate Officer/Principal | |
Becton Dickinson Immunocytometry Systems
Becton Dickinson Immunocytometry Systems Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Becton Dickinson Immunocytometry Systems manufactures medical instruments. The private company is based in San Jose, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 45 |
Taiwan | 2 |
Cayman Islands | 2 |
China | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 11 |
Finance | 4 |
Commercial Services | 3 |
Utilities | 2 |
Operational
Director/Board Member | 27 |
Chief Tech/Sci/R&D Officer | 14 |
Independent Dir/Board Member | 13 |
Founder | 9 |
Corporate Officer/Principal | 7 |
Most connected contacts
Insiders | |
---|---|
Peter Thompson | 39 |
Scott Stromatt | 11 |
John Bencich | 9 |
Daniel J. Burge | 7 |
Kathleen McKereghan Deeley | 6 |
- Stock Market
- Insiders
- Vijay Yabannavar
- Company connections